SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE DRUG OMISSION REASON
The reason why Systemic Anti-Cancer Therapy drugs were omitted from the Systemic Anti-Cancer Therapy Drug Cycle.
Description
The reason why Systemic Anti-Cancer Therapy drugs were omitted from the Systemic Anti-Cancer Therapy Drug Cycle.
For further guidance on recording of the National Codes, see the User Guidance provided by the National Disease Registration Service at: Downloads and guides.
National Codes
| Code | Description |
|---|---|
| 1 | PATIENT choice |
| 2 | ORGANISATION (Trust) issues |
| 3 | PATIENT (Clinical) factors |
| 4 | Toxicity |
Where Used
| Type | Link | How used |
|---|---|---|
| Class | ACTIVITY DRUG | has an attribute SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE DRUG OMISSION REASON of type SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE DRUG OMISSION REASON |
| Data Element | COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS TOXICITY GRADE (SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE DRUG OMISSION) | references in description SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE DRUG OMISSION REASON |
| Data Element | SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE DRUG OMISSION REASON | references in description SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE DRUG OMISSION REASON |
| Attribute | SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE PATIENT CLINICAL FACTORS DRUG OMISSION REASON | references in description SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE DRUG OMISSION REASON |